Matthew W Hale
Overview
Explore the profile of Matthew W Hale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Payet J, Baratta M, Christianson J, Lowry C, Hale M
Neuropharmacology
. 2025 Mar;
:110406.
PMID: 40081797
Long-term exposure to fluoxetine and other selective serotonin reuptake inhibitors alters social and anxiety-related behaviours, including social withdrawal, which is a symptom of several neuropsychiatric disorders. Adaptive changes in serotonergic...
2.
Moschonis G, Sarapis K, Resciniti S, Hall R, Yim K, Tonkovic M, et al.
Br J Nutr
. 2024 Oct;
:1-15.
PMID: 39468832
This study examined the efficacy of a probiotic in reducing depressive symptom severity in people with subthreshold depression. In a double-blind, randomised, placebo-controlled trial, a probiotic (1 × 10^9 live...
3.
Tyler M, Wright B, Raison C, Lowry C, Evans L, Hale M
Temperature (Austin)
. 2024 Aug;
11(3):266-279.
PMID: 39193043
The thermosensory system is relevant to both the conceptualization and treatment of depression. There is evidence that depression is associated with changes in thermoregulatory functioning, and that thermosensory pathways can...
4.
Tyler M, Wright B, Beaton R, Monger K, Raison C, Lowry C, et al.
Psychoneuroendocrinology
. 2023 Oct;
159:106420.
PMID: 37866124
Depression is the leading cause of disease burden globally. Existing antidepressant treatments that target the central nervous system have limited efficacy and come at the cost of significant side effects....
5.
Payet J, Stevens L, Russo A, Jaehne E, van den Buuse M, Kent S, et al.
Neuroscience
. 2023 Oct;
534:1-15.
PMID: 37852412
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for a variety of anxiety-, trauma- and stressor-related disorders. Although they are efficacious, therapeutic improvements require several weeks of treatment...
6.
De Luca S, Kivivali L, Chong K, Kirby A, Lawther A, Nguyen J, et al.
Behav Brain Res
. 2023 Oct;
457:114715.
PMID: 37838243
Calorie restriction (CR) has been shown to extend the mean and maximum lifespan in both preclinical and clinical settings. We have previously demonstrated that CR attenuates lipopolysaccharide (LPS)-induced fever and...
7.
Cooke Z, Resciniti S, Wright B, Hale M, Yao C, Tuck C, et al.
Neurogastroenterol Motil
. 2023 Sep;
35(12):e14684.
PMID: 37771208
Background: Evidence-based dietary management approaches for symptoms of dyspepsia are lacking. This study aimed to compare dietary factors, symptoms, quality of life (QOL) and salivary cortisol in dyspepsia participants and...
8.
Wright B, Hale M, Wertheim E
Psychosom Med
. 2023 May;
85(5):462-463.
PMID: 37252809
No abstract available.
9.
Eddy P, Wertheim E, Hale M, Wright B
Psychosom Med
. 2023 May;
85(5):450-460.
PMID: 37252807
Objective: Despite considerable research in the past 20 years into associations between the effort-reward imbalance (ERI) model and various health outcomes, the mechanisms responsible for the association remain unclear. Our...
10.
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
Uzungil V, Tran H, Aitken C, Wilson C, Opazo C, Li S, et al.
Neurotherapeutics
. 2022 Jul;
19(5):1662-1685.
PMID: 35861925
Depressed individuals who carry the short allele for the serotonin-transporter-linked promotor region of the gene are more vulnerable to stress and have reduced response to first-line antidepressants such as selective...